Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 20Pain, Postoperative 5Stomach Neoplasms 4Pancreatic Neoplasms 4Neoplasms 4Lung Neoplasms 4Carcinoma, Non-Small-Cell Lung 4Brain Neoplasms 4Prostatic Neoplasms 3Myoma 3Leiomyoma 3Head and Neck Neoplasms 3Glioblastoma 3Colorectal Neoplasms 3Agnosia 3Stomatitis 2Skin Neoplasms 2Postoperative Hemorrhage 2Ovarian Neoplasms 2Neoplasm Metastasis 2Melanoma 2Lymphoma, Non-Hodgkin 2Hemorrhage 2Fatigue 2Colonic Neoplasms 2Chronic Pain 2Carcinoma, Hepatocellular 2Water-Electrolyte Imbalance 1Vulvodynia 1Uterine Cervical Neoplasms 1

Interventions

sodium thiosulfate 1ebselen 1Tomography, X-Ray Computed 1Sodium Chloride 1Magnetic Resonance Imaging 1Hyaluronic Acid 1Hearing Tests 1Genetic Association Studies 1Acetylcysteine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Hearing Loss × Sodium Chloride × Clear all
NCT04262336 2023-07-06

Study to Evaluate Safety and Efficacy of DB-020 to Protect Hearing in Patients Receiving Cisplatin for Cancer Treatment

Decibel Therapeutics

Phase 1 Completed
22 enrolled

Ototoxicity, Hearing Loss

Data powered by HemOnc (CC BY 4.0) Colophon âš¡